Pharmaceutical Care Service in Diabetes

Not Applicable

Completed

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT02955875
• Lead Sponsor: Pusan National University

Brief Summary

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01
• Primary Completion: 2016-05
• Study Completion: 2016-06
• Study First Submitted: 2016-10-26
• Status Verified: 2016-11
• Study First Submitted QC: 2016-11-02
• Last Update Submitted: 2016-11-02
• Study First Posted: 2016-11-04
• Last Update Posted: 2016-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 257

Inclusion Criteria

Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria

• Who are diagnosed with type 2 diabetes mellitus for the first time
• Who need the education for medication or disease
• Who are with poorly controlled blood glucose
• Who have poor medication adherence
• Who have been hospitalized with diabetes complication or poorly controlled blood glucose
• Whose physician recommend the pharmaceutical care to them

Exclusion Criteria

Patients who meet one of the following criteria

• Who are with gestational diabetes
• Who are not able to respond to questionnaires
• Who are with severe condition such as cerebrovascular disease, mental disorder, and acquired immune deficiency syndrome
• Who are not able to be followed-up during 9 months in Pusan National University Hospital

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Medications knowledge at 9 months	9 months	Patients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.

Secondary Outcome Measures

Name	Time	Method
Proportion of participants taking statins 9 months	9 months
Proportion of participants managing diabetes complications at 9 months	9 months
Morisky Medication Adherence Scale at 9 months	9 months
5-level version of the EQ-5D at 9 months	9 months
EQ Visual Analogue Scale at 9 months	9 months
Problem Areas In Diabetes-Korean questionnaire at 9 months	9 months
Patient Satisfaction Questionnaire-Korean at 9 months	9 months
Cost-effectiveness of pharmaceutical care at 9 months	9 months
HbA1c level at 9 months	9 months
Random blood glucose level at 9 months	9 months
Blood pressure at 9 months	9 months
Cholesterol level at 9 months	9 months